{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:24:09Z","timestamp":1761488649426},"reference-count":13,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.3892\/ol.2011.269","type":"journal-article","created":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T09:54:55Z","timestamp":1300182895000},"page":"531-536","source":"Crossref","is-referenced-by-count":7,"title":["A clinical study of cytokine-induced killer cells for the treatment of refractory lymphoma"],"prefix":"10.3892","volume":"2","author":[{"given":"ZHI","family":"GUO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAO","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUE-PENG","family":"HE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAO-HUA","family":"TAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAN","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIA","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YU-JIE","family":"SHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAO-DONG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUI-REN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"key20180108093257_b1-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.174.1.139","article-title":"Use of a SCID mouse\/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity","volume":"174","author":"Schmidt-Wolf","year":"1999","journal-title":"Exp Med"},{"key":"key20180108093257_b2-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/1042819031000083082","article-title":"Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia","volume":"44","author":"Linn","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"key20180108093257_b3-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbmt.2004.11.019","article-title":"A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma","volume":"11","author":"Leemhuis","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20180108093257_b4-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1158\/1078-0432.CCR-05-2019","article-title":"Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study","volume":"12","author":"Chan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180108093257_b5-ol-02-03-0531","first-page":"1146","article-title":"Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma","volume":"10","author":"Shi","year":"2004","journal-title":"Clin Trial"},{"key":"key20180108093257_b6-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3324\/haematol.2009.019885","article-title":"Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation","volume":"95","author":"Kuci","year":"2010","journal-title":"Haematologica"},{"key":"key20180108093257_b7-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1517\/14712590903005552","article-title":"Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation","volume":"9","author":"Sangiolo","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"key20180108093257_b8-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-06-092817","article-title":"In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of anti-tumor activity","volume":"112","author":"Nishimura","year":"2008","journal-title":"Blood"},{"key":"key20180108093257_b9-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/intimm\/dxn042","article-title":"Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers","volume":"20","author":"Sangiolo","year":"2008","journal-title":"Inter Immunol"},{"key":"key20180108093257_b10-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/bbmt.2001.v7.pm11349808","article-title":"Expansion of cytotoxic CD3+CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation","volume":"7","author":"Alvarnas","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20180108093257_b11-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/ijc.21994","article-title":"Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma","volume":"119","author":"Kornacker","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180108093257_b12-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V86.9.3493.bloodjournal8693493","article-title":"Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+CD56+ killer cells","volume":"86","author":"Mehta","year":"1995","journal-title":"Blood"},{"key":"key20180108093257_b13-ol-02-03-0531","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2003-06-2125","article-title":"Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells","volume":"103","author":"Verneris","year":"2004","journal-title":"Blood"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2011.269\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T09:17:07Z","timestamp":1592385427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2011.269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,15]]},"published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.3892\/ol.2011.269"],"URL":"https:\/\/doi.org\/10.3892\/ol.2011.269","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,15]]}}}